Stay Updated
Press Releases
Momentum Building for Bipartisan CREATES Act
WASHINGTON, DC — Organizations representing patients and the research and development community today sent a letter urging Congressional leaders to pass the CREATES Act. Friends of Cancer Research, the National Multiple Sclerosis Society, and Patients For Affordable Drugs encouraged Congress to act soon to pass the bipartisan legislation that will help drive down drug prices […]
Press Releases
Statement on Luxturna’s $850,000 Price Tag
WASHINGTON, DC — The following statement was issued by David Mitchell, a patient with incurable blood cancer and the president and founder of Patients For Affordable Drugs, regarding the announcement of an $850,000 price tag for Luxturna, a new treatment that can correct a defective gene responsible for blindness in a small number of Americans. […]
Press Releases
Cancer Patients Dying Due to High Yescarta Price
WASHINGTON, DC — The following statement was issued by David Mitchell, a patient with incurable blood cancer and the president of Patients For Affordable Drugs, regarding reports of patients dying while waiting to receive Gilead’s $373,000 cancer drug, Yescarta. “My heart is breaking for these patients and their families. This situation is tragic, infuriating, and […]
Press Releases
Trump Administration Proposes Important Change To Lower Drug Prices
WASHINGTON, DC – Patients For Affordable Drugs applauded a proposal by the Trump Administration that would lower drug costs for Medicare patients. A key change in the Medicare Part D proposed rule would allow beneficiaries to pay coinsurance and deductibles based on discounted drug prices rather than the outrageous retail prices. By basing coinsurance and […]
Press Releases
WASHINGTON, DC – Americans are being extorted by Big Pharma, whose drugs they must take to improve their lives – and in some cases simply survive. That’s why, over the last two weeks, Patients For Affordable Drugs collected nearly 400 letters from patients urging President Donald Trump to keep his promise and allow Medicare to […]
Press Releases
Statement on the Nomination of Alex Azar as HHS Secretary
WASHINGTON, DC – Patients For Affordable Drugs Executive Director, Ben Wakana, issued the following statement regarding the nomination of Alex Azar to be the 24th Secretary of the U.S. Department of Health and Human Services. “Drug corporations have undue influence over health policy in America, and they use it to make money on the backs […]
Press Releases
Congressional Hearing to Spotlight Drug Corporation Patent Abuse
WASHINGTON, DC – The following statement was issued by David Mitchell, a cancer patient and the Founder of Patients For Affordable Drugs, regarding today’s House Judiciary Subcommittee hearing about drug company patent abuse and the inter partes review (IPR) process: “Today’s hearing touches on the heart of the problem with high drug prices. “One reason […]
Press Releases
Patients For Affordable Drugs Endorses Medicare Negotiation Bill
WASHINGTON, DC – Patients For Affordable Drugs expressed its strong support for the Medicare Drug Price Negotiation Act, introduced today. The bill would allow Medicare to negotiate lower drug prices on behalf of patients and taxpayers. “President Trump has called for the federal government to bargain over drug prices, and Mr. Cummings, Mr. Sanders, Mr. […]